We thank the following additional contributors to a companion publication to this article, “Cancer Treatment & Survivorship Facts & Figures 2012-2013”: Rick Alteri, MD; Ronald Barr, MD; Keysha Brooks-Coley, MA; Dana Chase, MD; John Daniel, MA; Stephen Edge, MD; Rachel Freedman, MD; James Gajewski, MD; Patricia Ganz, MD; Phillip Gray, MD; Natalie Hamm, RN, MSPH; Paul Jacobsen, PhD; Joan Kramer, MD; Alex Little, MD; Mark Litwin, MD; Ruth Rechis, PhD; Cheri Richards, MS; Lisa Richardson, MD; and Julia Rowland, PhD.
Article first published online: 14 JUN 2012
Published 2012 American Cancer Society, Inc.
CA: A Cancer Journal for Clinicians
Volume 62, Issue 4, pages 220–241, July/August 2012
How to Cite
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., Lin, C., Leach, C., Cannady, R. S., Cho, H., Scoppa, S., Hachey, M., Kirch, R., Jemal, A. and Ward, E. (2012), Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for Clinicians, 62: 220–241. doi: 10.3322/caac.21149
DISCLOSURES: The authors report no conflicts of interest.
This article is a US Government work and, as such, is in the public domain in the United States of America. doi: 10.3322/caac.21149. Available online at cacancerjournal.com
- Issue published online: 6 JUL 2012
- Article first published online: 14 JUN 2012
Vol. 62, Issue 5, 348, Article first published online: 9 JUL 2012
Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. CA Cancer J Clin 2012. Published 2012 American Cancer Society.